Purpose of this Study
If your child joins this study, they will:
- Be randomly assigned (like a coin flip) to 1 of 2 groups
-- One group will receive glasses and patching at the same time
-- The other group will receive glasses first and then receive patching only if necessary
Your child will visit our clinic 9 times over the course of 1 year. We will occasionally ask you to complete quality of life questionnaires related to your child's eyes and vision during the study.
- Be randomly assigned (like a coin flip) to 1 of 2 groups
-- One group will receive glasses and patching at the same time
-- The other group will receive glasses first and then receive patching only if necessary
Your child will visit our clinic 9 times over the course of 1 year. We will occasionally ask you to complete quality of life questionnaires related to your child's eyes and vision during the study.
Who Can Participate?
Eligibility
Children ages 3-12 who:
- Are diagnosed with amblyopia
- Have normal vision in their good eye
- Do not wear glasses or contacts
- Are not currently being treated for amblyopia
For more information about who can join this study, please contact the study team at DEC-RA@duke.edu.
- Are diagnosed with amblyopia
- Have normal vision in their good eye
- Do not wear glasses or contacts
- Are not currently being treated for amblyopia
For more information about who can join this study, please contact the study team at DEC-RA@duke.edu.
Age Range
3-12
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
We are doing this study to find out if treating amblyopia with glasses and patching at the same time improves vision as well as treating amblyopia first with glasses and then with patching, if needed.
Locations
Duke University Hospital
Other
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching for Amblyopia in Children 3 to <13 Years Old
Principal Investigator
Nathan
Cheung
Protocol Number
PRO00106669
NCT ID
NCT04378790
Phase
III
Enrollment Status
OPEN TO ACCRUAL